MedPath

effect of celery seed on obesity and fatty liver

Phase 2
Recruiting
Conditions
on-alcoholic fatty liver disease.
Fatty (change of) liver, not elsewhere classified
K76.0
Registration Number
IRCT20191124045488N1
Lead Sponsor
Ahvaz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
44
Inclusion Criteria

Overweight and obese patients (with BMI> 25)
With nonalcoholic fatty liver (grade 1, 2)
having ultrasound sheet with diagnosis of nonalcoholic fatty liver with radiologist and gastroenterologist approval

Exclusion Criteria

Pregnancy and lactation
liver transplantation
cigarette smoking, alcohol and drugs use
medications such as corticosteroids, amiodarone, tamoxifen, pracacillin, methotrexate
complete intravenous nutrition
heart failure, kidney disease, thyroid failure
Hemochromatosis and Wilson disease
Having positive test for hepatitis C, B and autoimmune hepatitis
alpha-antitrypsin deficiency

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath